Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 5, 2025
La AAPA y la Fundación PA dirigen los esfuerzos para mejorar las tasas de detección del cáncer colorrectal
GlobeNewswire
·
March 5, 2025
ALEXANDRIA, Virginia, March 05, 2025 (GLOBE NEWSWIRE) -- La Academia Americana de Asociados Médicos (AAPA) enorgullece de dirigir un esfuerzo destinado a mejorar las tasas de detección del cáncer colorrectal, que es el tercer tipo de cáncer más mortal de …
Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight
GlobeNewswire
·
March 5, 2025
New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight The growing incidence of genetic disorders and chronic illnesses, including cancer and rare inherited …
Essential Thrombocythemia Market to Witness Upsurge in Growth During the Study Period (2020–2034) | DelveInsight
GlobeNewswire
·
March 5, 2025
New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- Essential Thrombocythemia Market to Witness Upsurge in Growth During the Study Period (2020–2034) | DelveInsight The essential thrombocythemia market is expected to grow steadily due to increasing disease …
Global Healthcare Cybersecurity Market is Expected to Showcase a Significant Growth at a CAGR ~18% by 2032 | DelveInsight
GlobeNewswire
·
March 5, 2025
New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- Global Healthcare Cybersecurity Market is Expected to Showcase a Significant Growth at a CAGR ~18% by 2032 | DelveInsight The growing cybersecurity risks in healthcare, along with the increasing use of …
CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
GlobeNewswire
·
March 5, 2025
New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain CAR T-cell therapy is revolutionizing cancer …
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
GlobeNewswire
·
March 5, 2025
SAN FRANCISCO, March 05, 2025 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced the appointment of three distinguished industry and academic experts to its Clinical and Scientific Advisory …
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue
GlobeNewswire
·
March 5, 2025
Sanofi successfully prices EUR 1.5 billion of bond issue Paris, March 5, 2025. Sanofi announces that it has successfully priced its offering of EUR 1.5 billion of notes across 2 tranches: €850 million floating rate notes, due March 2027, bearing interest …
Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires
GlobeNewswire
·
March 5, 2025
Sanofi place 1,5 milliard d’euros d’emprunts obligataires Paris, 5 mars 2024. Sanofi annonce avoir placé avec succès une émission obligataire en 2 tranches (les « obligations ») pour un montant de 1,5 milliard d’euros : 850 millions d’euros d’obligations à …
Dr. Linus Anukwu Scholarship for Future Doctors Launches with Essay Contest Award
GlobeNewswire
·
March 5, 2025
CHAMPAIGN, Ill., March 05, 2025 (GLOBE NEWSWIRE) -- The Dr. Linus Anukwu Scholarship for Future Doctors proudly announces its inaugural $1,000 award, open to undergraduate students across the United States pursuing careers in medicine. Established to honor …
Researchers at NTHU and NHRI Develop New Drug for Treating Chronic Intestinal Inflammation
GlobeNewswire
·
March 5, 2025
HSINCHU, Taiwan, March 05, 2025 (GLOBE NEWSWIRE) -- Assistant Professor Yu-Hsin Chiu (邱于芯) from National Tsing Hua University (NTHU) in Taiwan and Director Hsing-Pang Hsieh (謝興邦) of the National Health Research Institutes (NHRI) have developed a drug to …
How Can We Make America Healthy Again?
GlobeNewswire
·
March 5, 2025
Washington, DC, March 05, 2025 (GLOBE NEWSWIRE) -- A new study from the International Food Information Council (IFIC), IFIC Spotlight Survey: Americans’ Perceptions …
BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper
GlobeNewswire
·
March 5, 2025
KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce that its Board of Directors has formally approved the …
The Academy of Nutrition and Dietetics Launches Online Hub to Counter Misinformation about Nutrition
GlobeNewswire
·
March 5, 2025
Chicago, March 05, 2025 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics (“the Academy”), today announced the launch of its new online resource hub dedicated to countering misinformation and uninformed opinions by promoting science-based …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
March 5, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 5 March 2025 at 17.00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
March 5, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 5.3.2025 KLO 17.00 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
Spark Biomedical Receives Health Canada’s Medical Device License for Sparrow Ascent Opioid Withdrawal Treatment
GlobeNewswire
·
March 5, 2025
Dallas, TX, March 05, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow AscentTM, an FDA-cleared non-invasive, drug-free, …
Longeveron® to Present at the 37th Annual Roth Conference
GlobeNewswire
·
March 5, 2025
MIAMI, March 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will …
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
GlobeNewswire
·
March 5, 2025
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …
Pow.Bio Unveils State-of-the-Art Facility in Alameda, Expanding Biomanufacturing Capabilities to Support Demand for Continuous Fermentation
GlobeNewswire
·
March 5, 2025
ALAMEDA, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Pow.Bio, a leader in innovative biomanufacturing solutions, is pleased to announce the opening of its new cutting-edge facility in Alameda, California. The new 25,000 sq ft facility, located at Marina …
Parexel Announces Updates to Board of Directors
GlobeNewswire
·
March 5, 2025
Jeff Bernstein, Partner, Private Equity, Goldman Sachs Asset Management, and Co-Head, Goldman Sachs Healthcare Private Equity Investing, joins as new Director. Mr. Bernstein succeeds Michael Bruun in the Goldman Sachs Board seat as part of a planned …